Literature DB >> 17081125

Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.

Thomas Rückrich1, Jens Brandenburg, Alexander Cansier, Margret Müller, Stefan Stevanović, Klaus Schilling, Bernd Wiederanders, Alexander Beck, Arthur Melms, Michael Reich, Christoph Driessen, Hubert Kalbacher.   

Abstract

Cathepsin S (CatS) is a lysosomal cysteine protease of the papain family, the members of which possess relatively broad substrate specificities. It has distinct roles in major histocompatibility complex (MHC) class II-associated peptide loading and in antigen processing in both the MHC class I and class II pathways. It may therefore represent a target for interference with antigen presentation, which could be of value in the therapy of (auto)immune diseases. To obtain more detailed information on the specificity of CatS, we mapped its cleavage site preferences at subsites S3-S1' by in vitro processing of a peptide library. Only five amino acid residues at the substrate's P2 position allowed for cleavage by CatS under time-limited conditions. Preferences for groups of amino acid residues were also observed at positions P3, P1 and P1'. Based on these results, we developed highly CatS-sensitive peptides. After processing of MHC class II-associated invariant chain (Ii), a natural protein substrate of CatS, we identified CatS cleavage sites in Ii of which a majority matched the amino acid residue preference data obtained with peptides. These observed cleavage sites in Ii might be of relevance for its in vivo processing by CatS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081125     DOI: 10.1515/BC.2006.188

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  9 in total

1.  Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.

Authors:  Nicolas Lützner; Hubert Kalbacher
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

2.  Inducing efficient cross-priming using antigen-coated yeast particles.

Authors:  Shanshan W Howland; Takemasa Tsuji; Sacha Gnjatic; Gerd Ritter; Lloyd J Old; Karl Dane Wittrup
Journal:  J Immunother       Date:  2008-09       Impact factor: 4.456

3.  Sensitization prevalence, antibody cross-reactivity and immunogenic peptide profile of Api g 2, the non-specific lipid transfer protein 1 of celery.

Authors:  Gabriele Gadermaier; Michael Hauser; Matthias Egger; Rosetta Ferrara; Peter Briza; Keity Souza Santos; Danila Zennaro; Tamara Girbl; Laurian Zuidmeer-Jongejan; Adriano Mari; Fatima Ferreira
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

4.  A Missing Switch in Peptide Exchange for MHC Class II Molecules.

Authors:  Christian Freund; Thomas Höfer
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

Review 5.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12

6.  Three dimensional structure directs T-cell epitope dominance associated with allergy.

Authors:  Scott J Melton; Samuel J Landry
Journal:  Clin Mol Allergy       Date:  2008-09-15

7.  Cathepsin S signals via PAR2 and generates a novel tethered ligand receptor agonist.

Authors:  Sarina B Elmariah; Vemuri B Reddy; Ethan A Lerner
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

8.  Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins.

Authors:  Lili Cai; Jianbo Zhang; Renying Zhu; Weixing Shi; Xiaobing Xia; Mark Edwards; William Finch; Anthony Coombs; Ju Gao; Kangwen Chen; Sophie Owen; Shisong Jiang; Wenshu Lu
Journal:  Oncotarget       Date:  2017-08-24

Review 9.  Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics.

Authors:  Ryan Brown; Sridesh Nath; Alnardo Lora; Ghassan Samaha; Ziyad Elgamal; Ryan Kaiser; Clifford Taggart; Sinéad Weldon; Patrick Geraghty
Journal:  Respir Res       Date:  2020-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.